Mangafodipir trisodium
锰福地吡三钠
Report date: 2026/04/07 20:00:20
NME
Base Information
Drug NameMangafodipir trisodium
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date1997/11/26
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIc Targets As
China Registration ClassN/A
Develop Information
Active CompaniesNational Institute Of Neurological Disorders And Stroke
Inactive CompaniesIc Targets AsEgetis Therapeutics AB
Active Indications
Inactive Indications